[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![OzmosiHealth Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1055982930.png) Ozmosi [@OzmosiHealth](/creator/twitter/OzmosiHealth) on x 2635 followers
Created: 2025-07-18 11:32:19 UTC

$OCGN First patient dosed in Phase 2/3 GARDian3 trial for OCU410ST, a gene therapy candidate for Stargardt Disease, announced by Ocugen, Inc.

More Info: $XBI $IBB $XPH $PPH

![](https://pbs.twimg.com/media/GwIwXWgWMAAjLvN.jpg)

XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1946171170883252410/c:line.svg)

**Related Topics**
[$pph](/topic/$pph)
[$xph](/topic/$xph)
[$ibb](/topic/$ibb)
[$xbi](/topic/$xbi)
[more info](/topic/more-info)
[$ocgn](/topic/$ocgn)

[Post Link](https://x.com/OzmosiHealth/status/1946171170883252410)